» Articles » PMID: 25315251

Diagnostic Transitions in Mild Cognitive Impairment by Use of Simple Markov Models

Overview
Specialties Geriatrics
Psychiatry
Date 2014 Oct 16
PMID 25315251
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mild cognitive impairment (MCI) is a complex entity, which can involve persistence of the symptoms, conversion to dementia or improvement. The aim was to study the transitions between normal cognitive ageing and three MCI subtypes by using Markov transition models for different intervals between baseline and the follow-up assessment.

Methods: A total of 294 participants over 50 years old attending primary care centres were assessed and diagnosed at baseline as multi-domain amnestic MCI (22 participants), single domain amnestic MCI (44), non-amnestic MCI (non-amnestic MCI) (26) or controls (202). We adopted an overlapping interval strategy by constructing six different mid-point time intervals according to the time between the baseline and the follow-up assessment. We used Markov transition models to study diagnostic changes in the groups in the different time intervals

Results: The rate of change was lowest in the control group. In the single domain amnestic MCI and non-amnestic MCI groups, the same diagnosis was usually retained or changed to normal cognitive functioning. In the multi-domain amnestic MCI group, the rate of transition to normal functioning was lowest, and the conversion to dementia was the highest of all groups. The best fit to the Markov models was found for the period between 18-21 months, whereas the worst fit was for the period between 9-15 months

Conclusions: Markov models provide a comprehensive view of transitions between MCI and normal cognitive functioning. Time interval strategies seem to provide a good opportunity to monitor diagnostic transitions, although wider intervals including subsequent assessments are needed. The low rates of conversion to dementia are discussed.

Citing Articles

An Interpretable Population Graph Network to Identify Rapid Progression of Alzheimer's Disease Using UK Biobank.

Meng W, Inampudi R, Zhang X, Xu J, Huang Y, Xie M medRxiv. 2024; .

PMID: 38585886 PMC: 10996760. DOI: 10.1101/2024.03.27.24304966.


Usability of an Embodied CAVE System for Spatial Navigation Training in Mild Cognitive Impairment.

Tuena C, Serino S, Stramba-Badiale C, Pedroli E, Goulene K, Stramba-Badiale M J Clin Med. 2023; 12(5).

PMID: 36902733 PMC: 10003531. DOI: 10.3390/jcm12051949.


Brain Atrophy and Clinical Characterization of Adults With Mild Cognitive Impairment and Different Cerebrospinal Fluid Biomarker Profiles According to the AT(N) Research Framework of Alzheimer's Disease.

Rivas-Fernandez M, Lindin M, Zurron M, Diaz F, Aldrey-Vazquez J, Pias-Peleteiro J Front Hum Neurosci. 2022; 16:799347.

PMID: 35280203 PMC: 8914376. DOI: 10.3389/fnhum.2022.799347.


Cannabis cessation among youth: rates, patterns and academic outcomes in a large prospective cohort of Canadian high school students.

Zuckermann A, Gohari M, de Groh M, Jiang Y, Leatherdale S Health Promot Chronic Dis Prev Can. 2020; 40(4):95-103.

PMID: 32270667 PMC: 7197643. DOI: 10.24095/hpcdp.40.4.01.


Longitudinal Patterns of the Tip-of-the-Tongue Phenomenon in People With Subjective Cognitive Complaints and Mild Cognitive Impairment.

Campos-Magdaleno M, Leiva D, Pereiro A, Lojo-Seoane C, Mallo S, Nieto-Vieites A Front Psychol. 2020; 11:425.

PMID: 32231626 PMC: 7083146. DOI: 10.3389/fpsyg.2020.00425.